# PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

> **NCT05161728** · NA · UNKNOWN · sponsor: **Roderick van den Bergh** · enrollment: 150 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PSMA-PET/CT

## Key facts

- **NCT ID:** NCT05161728
- **Lead sponsor:** Roderick van den Bergh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-19
- **Primary completion:** 2025-10-19
- **Final completion:** 2025-10-19
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161728, "PSMA Response in Metastasized Hormone Sensitive Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05161728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*